Dexcel Devices
Founded in 1968 and headquartered in Or Akiva, Israel, Dexcel Pharma engages in the discovery, development, manufacture, and marketing of prescription drug formulations for modified-release drug delivery technologies.
Country/Area ：India
Company Email ：office@dexcel.com
Industry ：Health CareHealthcareMachineryPharmaceuticals
Company address ：1 Dexcel St, Or Akiva, Southern District, 3060000, Israel
Company website ：*****
Company phone ：+44 1327312266
Established ：1968
Company Revenue ：$337,568,000
Number of employees ：1000
SIC Code ：28283
NAICS Code ：32325
Main Products ：Branded RxGenericsOTC
Company News
New Drug Filing for Cenobamate Accepted for Review in Canada and Israel
Aug 9, 2022
SK Biopharmaceuticals is eligible to receive milestones for future approval and commercialization in Canada and Israel PANGYO, South Korea, Aug. 9, 2022 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd. announced that Health Canada has accepted Paladin Labs Inc.'s filing of a New Drug...
Aug 9, 2022
Kriya Therapeutics Raises $270M in Series C FinancingMay 17, 2022
Kriya Therapeutics, Inc., a Redwood City, CA and Research Triangle Park, NC-based fully integrated gene therapy company advancing novel technologies and therapeutics, raised $270m in Series C financing. The round was led by Patient Square Capital, with participation from Bluebird Ventures, CAM Capital, Dexcel Pharma, Foresite Capital, JDRF T1D Fund, Lightswitch Capital, Narya Capital, QVT, […] The post Kriya Therapeutics Raises $270M in Series C Financing appeared first on FinSMEs.
May 17, 2022Business Info
CIN ：U51909MH2018PTC308498
Registered State ：Maharashtra
Registrar Of Companies ：RoC - Mumbai
Category ：Company Limited by Shares
Sub Category ：Non-Government
Company Class ：Private
Company Status ：Active
Registered Office Address ：PLOT NO 8, LOKSEVA NAGAR, BHAMTI ROAD, NEAR NAG MANDIR NAGPUR Nagpur-440022 Maharashtra
Authorized Cap ：500000.00
Paidup Capital ：100000.00
Web Summary
Q1: What is the address of Dexcel Devices' headquarters?
A1: The address of Dexcel Devices' headquarters is 1 Dexcel St., Or Akiva, Israel.
Q2: What products does Dexcel Devices manufacture and commercialize?
A2: Dexcel Devices manufactures and commercializes an extensive portfolio of branded and generic drugs, including oralsolid dosages, with a focus on providing highquality products to patients and partners worldwide.
Q3: In which industry is Dexcel Devices primarily involved?
A3: Dexcel Devices is primarily involved in the pharmaceutical industry, specifically in the development, manufacturing, and commercialization of innovative drugs.
Q4: What services does Dexcel Devices offer to its customers?
A4: Dexcel Devices offers a range of services, including global quality standard management, responsive customer service, competitive pricing, and timely delivery, ensuring product supply consistency and reliability.
Q5: How many employees does Dexcel Devices have worldwide?
A5: According to the provided information, Dexcel Devices has 1200+ employees worldwide.
Q6: What is the total investment made by Dexcel Devices in Research and Development (R&D) and Capital Expenditure (Capex) over the last decade?
A6: The company has invested $500M in R&D and Capex over the last decade, demonstrating its commitment to innovation and growth.
Q7: In which countries does Dexcel Devices have subsidiaries or offices?
A7: According to the provided information, Dexcel Devices has subsidiaries or offices in Israel, United States (Edenbridge Pharmaceuticals), United Kingdom (Dexcel Pharma Limited), Germany (Dexcel Pharma GmbH), Singapore (AmediusTec Ltd), and Austria (NICApur Micronutrition GmbH).
Q8: What is the name of Dexcel Devices' founder and Executive Chairman?
A8: The founder and Executive Chairman of Dexcel Devices is Dan Oren.
A1: The address of Dexcel Devices' headquarters is 1 Dexcel St., Or Akiva, Israel.
Q2: What products does Dexcel Devices manufacture and commercialize?
A2: Dexcel Devices manufactures and commercializes an extensive portfolio of branded and generic drugs, including oralsolid dosages, with a focus on providing highquality products to patients and partners worldwide.
Q3: In which industry is Dexcel Devices primarily involved?
A3: Dexcel Devices is primarily involved in the pharmaceutical industry, specifically in the development, manufacturing, and commercialization of innovative drugs.
Q4: What services does Dexcel Devices offer to its customers?
A4: Dexcel Devices offers a range of services, including global quality standard management, responsive customer service, competitive pricing, and timely delivery, ensuring product supply consistency and reliability.
Q5: How many employees does Dexcel Devices have worldwide?
A5: According to the provided information, Dexcel Devices has 1200+ employees worldwide.
Q6: What is the total investment made by Dexcel Devices in Research and Development (R&D) and Capital Expenditure (Capex) over the last decade?
A6: The company has invested $500M in R&D and Capex over the last decade, demonstrating its commitment to innovation and growth.
Q7: In which countries does Dexcel Devices have subsidiaries or offices?
A7: According to the provided information, Dexcel Devices has subsidiaries or offices in Israel, United States (Edenbridge Pharmaceuticals), United Kingdom (Dexcel Pharma Limited), Germany (Dexcel Pharma GmbH), Singapore (AmediusTec Ltd), and Austria (NICApur Micronutrition GmbH).
Q8: What is the name of Dexcel Devices' founder and Executive Chairman?
A8: The founder and Executive Chairman of Dexcel Devices is Dan Oren.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
